Functional CD32 Molecules on Human NK Cells

References

• Herberman R. B. NK cells and other natural effector cells. Academic Press, New York 1982
   Google Scholar
• Trinchieri G. Biology of natural killer cells. Advances in Immunology 1989; 47: 187–376
   PubMed Web of Science ®Google Scholar
• Whiteside T. L., Herberman R. B. The role of natural killer cells in human disease. Clinical Immunology and Immunopathology 1989; 52: 1–23
   PubMedGoogle Scholar
• Hersey P., Bolhuis R. “Nonspecific” MHC-W-stricted killer cells and their receptors. Immunology Today 1987; 8: 233–239
   PubMedGoogle Scholar
• Lanier L. L., Corliss B., Phillips J. H. Arousal and inhibition of human NK cells. Immunological Reviews 1997; 155: 145–154
   PubMed Web of Science ®Google Scholar
• Chambers W. H., Vujanovic N. L., DeLeo A. B., Olsmwy M. W., Herberman R. B., Hiserodt J. C. Monoclonal antibody to a triggering structure expressed on rat natural killer (NK) cells and adherent lymphokine activated killer (A-LAK) cells. Journal of Experimental Medicine 1989; 169: 1373–1389
   PubMed Web of Science ®Google Scholar
• Lanier L. L., Ruitenberg J. J., Phillips J. H. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. Journal of Immunology 1988; 141: 3418–3485
   Google Scholar
• Perussia B., Trinchieri G., Jackson A., Warner N. L., Faust J., Rumpold H., Rumpold D., Lanier L. L. The Fc receptor for IgG on human natural killer cells: phenotypic, functional and comparative studies using monoclonal antibodies. Journal of Immunology 1984; 133: 180–189
   PubMed Web of Science ®Google Scholar
• Carpen O., Saksela E. Directed exocytosis in the NK cell-mediated cytotoxicity. A review. Natural Immunity and Cell Growth Regulation. 1987; 7: 1–12
   Google Scholar
• Liu C. -C., Walsh C. M., Young J. D.-E. Perforin: structure and function. Immunology Thy 1995; 16: 194–198
   Web of Science ®Google Scholar
• Shi L., Kraut R. P., Aebersold R., Greenberg A. H. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. Journal of Experimental Medicine 1992; 175: 553–562
   PubMed Web of Science ®Google Scholar
• Montel A. H., Bochan M. R., Hobbs J. A., Lynch D. A., Brahmi Z. Fas involvement in cytotoxicity mediated by human NK cells. Cellular Immunology 1995; 166: 236–245
   PubMed Web of Science ®Google Scholar
• Oshimi Y., Oda S., Honda Y., Nagata S., Miyazaki S. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. Journal of Immunology 1996; 157: 2909–2915
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Fitz L., Ryan M., Hewick R. M., Clark S. C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of nutural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. Journal of Experimental Medicine. 1989; 170: 827–846
   PubMed Web of Science ®Google Scholar
• Chan S. H., Perussia B., Gupta J. W., Kobayashi M., Pop-Sit M., Young H. A., Wolf S. F., Young D., Clark S. C., Trinchieri G. Induction of IFN-γ production by NK cell stimulatory factor (NKSF): Characterization of the responder cells and synergy with other inducers. Journal of Experimental Medicine 1991; 173: 869–879
   PubMed Web of Science ®Google Scholar
• Morel P. A., Oriss T. B. Crossregulation between Thl and Th2 cells. Critical Reviews in Immunology 1998; 18: 275–303
   PubMed Web of Science ®Google Scholar
• Orange J. S., Biron C. A. An absolute and restricted requirement for JL-12 in natural killer cell IFN-γ Droduction and antiviral defense. Journal of Immunology 1996; 156: 1138–1142
   PubMed Web of Science ®Google Scholar
• Young H. A., Hardy K. J. Interferon-γ: Producer cells, activation stimuli, and molecular genetic regulation. Pharmacology and Therapeutics 1990; 45: 137–151
   PubMed Web of Science ®Google Scholar
• Anegnon I., Cuturi M. C., Trinchieri G., Perussia B. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. Journal of Erperimental Medicine 1988; 167: 452–472
   PubMed Web of Science ®Google Scholar
• Azzoni L., Anegon I., Calabretta B., Perussia B. Ligand binding to Fc gamma R induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. Journal of Immunology 1995; 154: 491–499
   PubMed Web of Science ®Google Scholar
• Ortaldo J. R., Mason A. T., O'Shea J. J. Recep tor-indud death in human natural killer cells: Involvement of CD16. Journal of Experimental Medicine 1995; 181: 339–344
   PubMed Web of Science ®Google Scholar
• Moretta A., Biassoni R., Bottino C., Pende D., Vitale M., Poggi A., Mingari M. C., Moretta L. Major histo-compatibility complex class I-specific receptors on human natural killer cells and T lymphocytes. Immunological Reviews 1997; 155: 105–117
   PubMed Web of Science ®Google Scholar
• Long E. O., Burshtyn D. N., Clark W. P., Peruzzi M., Raja-Gopalan S., Rojo S., Wagtmann N., Winter C. C. Killer cell inhibitory receptors: diversity, specificity and function. Immunological Reviews 1997; 155: 135–144
   PubMed Web of Science ®Google Scholar
• Borrego F., Ulbrecht M., Weiss E. H., Coligan J. E., Brooks A. G. Recognition of human histocompatibil-ity leukocyte antigen (HLA)-E complexed with HLA-class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. Journal of Experimental Medicine 1998; 187: 813–818
   PubMed Web of Science ®Google Scholar
• Braud V. M., Allan D. S., O'Callaghan C. A., Sodersmm K., D'Andrea A., Ogg G. S., Lazetic S., Young N. T., Bell J. I., Phillips J. H., Lanier L. L., McMichael A. J. HLA-E binds to natural killer cell receptors CD94/MKG2A, B and C. Nature 1998; 391: 795–799
   PubMed Web of Science ®Google Scholar
• Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D. HLA-E is the major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proceedings of the National Academy of Science USA 1998; 95: 5199–5204
   PubMed Web of Science ®Google Scholar
• Burshtyn D. N., Sharenberg A. M., Wagtmann N., Rajagopalan S., Berrado K., Yi T., Kinet J., Long E. O. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 1996; 4: 77–85
   PubMed Web of Science ®Google Scholar
• Leibson P. J. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 1997; 6: 655–661
   PubMed Web of Science ®Google Scholar
• Metes D., Galatiuc C., Moldovan I., Morel P. A., Chambers W. H., DeLeo A. B., Rabinowich H., Schall R., Whiteside T. L., Sulica A., Herberman R. B. Expression and function of FcγRII on human natural killer cells. Natural Immunity 1994; 13: 289–300
   PubMedGoogle Scholar
• Metes D., Ernst L. K., Chambers W. H., Sulica A., Herber-Man R. B., Morel P. A. Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcγIIC gene. Blood 1998; 91: 2369–2380
   PubMed Web of Science ®Google Scholar
• Mantzioris B. X., Berger M. F., Sewell W., Zola H. Expression of the Fc receptor for IgG (FcγRWCDw32) by human circulating T and B lymphocytes. Journal of Immunology 1993; 150: 5175–5184
   PubMed Web of Science ®Google Scholar
• van de Winkel J. G. J., Capel P. J. A. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunology Today 1993; 14: 215–221
   PubMedGoogle Scholar
• Ravetch J. V., Kinet J. -P. Fc receptors. Annual Review of Immunology 1991; 9: 457–492
   PubMed Web of Science ®Google Scholar
• Hulett M. D., Hogarth P. M. Molecular basis of Fc receptor function. Advances in Immunology 1994; 57: 1–127
   PubMed Web of Science ®Google Scholar
• Sedmak D. D., Davis H. H., Singht U., van de Winkel J. G. J., Anderson C. L. Expression of IgG Fc receptor antigens in placenta and on endothelial cells in humans. American Journal of Parhology 1991; 138: 175–181
   PubMed Web of Science ®Google Scholar
• Stuart S. G., Trountstine M. L., Vaux D. J. T., Koch T., Martens C. L., Mellman I., Moore K. W. Isolation and expression of cDNA clones encoding a human receptor for IgG. Journal of Experimental Medicine 1987; 166: 1668–1684
   PubMed Web of Science ®Google Scholar
• Stuart S. G., Sinister N. E., Clarkson S. B., Kacinski B. M., Sharpiro M., Mellman I. Human IgG Fc receptor (FcγRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium. EMBO Journal 1989; 8: 3657–3666
   PubMed Web of Science ®Google Scholar
• Brooks D. G., Qiu W. Q., Luster A. D., Ravetch J. V. Structure and expression of human IgG FcγRII (CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. Journal of Experimental Medicine 1989; 170: 1369–1385
   PubMed Web of Science ®Google Scholar
• Qiu W. Q., de Bruin D., Brownstein B. H., Pearse R., Ravetch J. V. Organization of the human and mouse low-affinity FcγR genes: evidence for duplication and recombination. Science 1990; 248: 732–735
   PubMed Web of Science ®Google Scholar
• Warmerdan P. A. M., Nabben N. M. J. M., van de Graaf S. A. R., van de Winkel J. G. J., Capel P. J. A. The human low-affinity immunoglobulin G Fc receptor IIC is a result of an unequal crossover event. Journal of Biological Chemistry. 1993; 268: 7346–7349
   PubMed Web of Science ®Google Scholar
• Van den Herik-Oudijk I. E., Westerdaal N. A. C., Hen-Riquez N. V., Capel P. J. A., Van de Winkel J. G. J. Functional analysis of human FcγRII (CD32) isoforms expressed in B cells. Journal of lmmunology 1994; 152: 574–585
   PubMed Web of Science ®Google Scholar
• Shepp D. H., Chakrabarti S., Moss B., Quinnan G. V. J. Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus. Journal of Infectious Diseases 1988; 157: 1260–1264
   PubMed Web of Science ®Google Scholar
• Hashimoto G., Wright P. F., Karzon D. J. Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. Journal of Infectious Diseases 1983; 148: 785–794
   PubMed Web of Science ®Google Scholar
• Gill I., Agah R., Hu E., Mazumder A. Synergistic antitumor effects of interleukin 2 and the monoclonal Lym-1 against human Burkitt lymphoma cells in vitro and in vivo. Cancer Research 1989; 49: 5377–5379
   PubMed Web of Science ®Google Scholar
• Abrams S. I., Brahmi. Target cell directed NK inactivation. Concomitant loss of NK and antibody-dependent cellular cytotoxicity activities. Journal of Immunology 1988; 140: 2090–2095
   PubMed Web of Science ®Google Scholar
• Christiaansen J. E., Sears D. W. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies. Cancer Research 1984; 44: 3712–3718
   PubMed Web of Science ®Google Scholar
• Timonen T., Ortaldo J., Herberman R. B. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. Journal of Experimental Medicine 1981; 153: 569–582
   PubMed Web of Science ®Google Scholar
• Cuturi M. C., Anegnon I., Sherman F., Loudon R., Clark S. C., Perussia B., Trinchieri G. Production of hematopoietic colony-stimulating factors by human natural killer cells. Journal of Experimental Medicine 1989; 169: 569–583
   PubMed Web of Science ®Google Scholar
• Cambier J. C. Antigen and Fc receptor signaling: The awesome power of the immunreceptor tyrosine based activation morif (ITAM). Journal of Immunology 1995; 155: 3281–3285
   PubMed Web of Science ®Google Scholar
• Wirthmueller U., Kurosaki T., Murakami M. S., Ravetch J. V. Signal transduction by FcγIII (CD16) is mediated through the γ chain. Journal of Experimental Medicine 1992; 175: 1381–1390
   PubMed Web of Science ®Google Scholar
• Pignata C., Prasad K. V. S., Robertson M. J., Levine H., Rudd C. E., Ritz J. FcγRIIIA-mediated signaling involves src-family Ick in human natural killer cells. Journal of Immunology 1993; 151: 6794–6800
   PubMed Web of Science ®Google Scholar
• Lanier L. L., Yu G., Phillips J. H. Analysis of FCprn (CD16) membrane expression and association with CD3 and Fcri-γ by site-directed mutation. Journal of Immunology 1991; 146: 1571–1576
   PubMed Web of Science ®Google Scholar
• Brumbaugh K. M., Binstadt B. A., Billadeau D. D., Schoon R. A., Dick C. J., Ten R. M., Leibson P. J. Functional role for Syk tyrosine kinase in natural killer cell-mediated, natural cytotoxicity. Journal of Experimental Medicine. 1997; 186: 1965–1974
   PubMed Web of Science ®Google Scholar
• Reth M. Antigen receptor tail clue. Nature 1989; 338: 383–384
   PubMed Web of Science ®Google Scholar
• Odin J. A., Edberg J. C., Painter C. J., Kimberley R. P., Unkeless J. C. Regulation of phagocytosis and[Ca2+]i flux by distinct regions of an Fc receptor. Science 1991; 254: 1785–1788
   PubMed Web of Science ®Google Scholar
• Ghazizadeh S., Bolen J. B., Fleit H. B. Physical and functional association of src-related protein kinases with FcγRII in monocytic THP-1 cells. Journal of Biological Chemisry 1994; 269: 8878–8884
   PubMed Web of Science ®Google Scholar
• Weiss A., Stobo J. D. Requirement for the coexpression of T3 and the T cells antigen receptor on a malignant human T cell line. Journal of Experimental Medicine 1984; 160: 1284–1299
   PubMed Web of Science ®Google Scholar
• Masuda M., Roos D. Association of all three types of FcγR (CD64, CD32, and CD 16) with a γ-chain homodimer in cultured human monocytes. Journal of Immunology 1993; 151: 7188–7195
   PubMed Web of Science ®Google Scholar
• Selvaraj P., Rosse W. F., Silber R., Springer T. A. The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal hemoglobinuria. Nature 1988; 333: 565–567
   PubMed Web of Science ®Google Scholar
• Huizinga T. W. J., van der Schoot C. E., Joost C., Klassen R., Kleijer M., Vondem Borne A. E. G. K., Roos D., Tette-Roo P. A. T. The PI linked receptor FcγRIII is released on stimulation of neutrophils. Nature 1988; 333: 667–669
   PubMed Web of Science ®Google Scholar
• Salmon J. E., Millard S. S., Schachter L. A., Amett F. C., Ginzler E. M., Gourley M. F., Ramsey-Golgman R., Peterson M. G. E., Kimberly R. P. FWIA alleles are heritable risk factors for lupus nethritis in African Americans. Journal of Clinical Investigation. 1996; 97: 1348–1354
   PubMed Web of Science ®Google Scholar
• Sammaritano L. R., Ng S., Sobel R., Lo S. K., Simantov R., Furie R., Kaell A., Silverstein R., Salmon J. E. Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis. Arthritis and Rheumatism 1997; 40: 1998–2006
   PubMed Web of Science ®Google Scholar
• Wannerdan P. A. M., van de Winkel J. G. J., Vlug A., et al. A single amino acid in the second Ig-like domain of the human Fcγ receptor II is critical for human IgG2 binding. Journal of Immology 1991; 147: 1338–1343
   PubMed Web of Science ®Google Scholar
• Sanders L. A., van de Winkel J. G., Rijkers G. T., Voor-shorst-Ogink M. M., de Haas M., Capel P. J., Zegers B. J. Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. Journal of Infectious Diseases 1994; 170: 854–861
   PubMed Web of Science ®Google Scholar
• Bredius R. G. M., Derkx B. H. F., Fijen C. A. P., de Wit T. P. M., de Haas M., Weening R. S., van de Winkel J. G. J., Out T. A. Fcγ receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. Journal of Infectious Diseases 1994; 170: 848–853
   PubMed Web of Science ®Google Scholar